Losartan

mitogen-activated protein kinase 3 ; Mus musculus







12 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33145772 Cardiac pathology in mucopolysaccharidosis I mice: Losartan modifies ERK1/2 activation during cardiac remodeling. 2021 May 2
2 34761239 Mechanical activation of the angiotensin II type 1 receptor contributes to abdominal aortic aneurysm formation. 2021 3
3 30965084 Genetic disruption of guanylyl cyclase/natriuretic peptide receptor-A upregulates renal (pro) renin receptor expression in Npr1 null mutant mice. 2019 Apr 1
4 30971441 The Angiotensin Receptor Blocker Losartan Suppresses Growth of Pulmonary Metastases via AT1R-Independent Inhibition of CCR2 Signaling and Monocyte Recruitment. 2019 May 15 1
5 31284709 Transforming Growth Factor β Receptor Type I Inhibitor, Galunisertib, Has No Beneficial Effects on Aneurysmal Pathological Changes in Marfan Mice. 2019 Jul 9 1
6 25779879 Losartan increases bone mass and accelerates chondrocyte hypertrophy in developing skeleton. 2015 May 3
7 25122005 Role of vascular smooth muscle PPARγ in regulating AT1 receptor signaling and angiotensin II-dependent hypertension. 2014 1
8 22550139 MMP-2 regulates Erk1/2 phosphorylation and aortic dilatation in Marfan syndrome. 2012 Jun 8 1
9 21109230 Angiotensin II induces interleukin-6 synthesis in osteoblasts through ERK1/2 pathway via AT1 receptor. 2011 Mar 1
10 21609620 [Experimental study of (Pro)renin receptor siRNA inhibiting retinal neovascularization]. 2011 Mar 1
11 18827741 Losartan prevents sepsis-induced acute lung injury and decreases activation of nuclear factor kappaB and mitogen-activated protein kinases. 2009 May 1
12 19500499 [Losartan inhibits high glucose-induced CTGF expression via ERK1/2 MAPK pathways in mouse mesangial cells]. 2009 Jun 3